Shenzhen Salubris Pharmaceuticals Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CNY 4,470.465 million compared to CNY 4,651.876 million a year ago. Operating income was CNY 846.081 million compared to CNY 1,719.961 million a year ago. Net income was CNY 715.201 million compared to CNY 1,458.223 million a year ago. Basic earnings per share from continuing operations was CNY 0.68 compared to CNY 1.39 a year ago.